The incidence of adenocarcinoma and dysplasia in Barrett's esophagus report on the Cleveland Clinic Barrett's esophagus registry

American Journal of Gastroenterology

Volumn 94, Issue 8, 1999, Pages 2037-2042

  Barry O'Connor, J ^a   Falk, Gary W ^a   Richter, Joel E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER RISK; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CROSS-SECTIONAL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OHIO; PRECANCEROUS CONDITIONS; REGISTRIES;

EID: 0033180027     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00331-7     Document Type: Article

References (17)

1. Winters C, Spurling TJ, Chobanian SJ, et al. Barren's esophagus: A prevalent occult complication of gastroesophageal reflux. Gastroenterology 1987;92:118-24.
2. Fera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and the esophagogastric junction. Gastroenterology 1993;104:510-3.
3. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus: Development of dysplasia and adenocarcinoma. Gastroenterology 1989;96:1249 -56.
4. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-5.
5. Katz D, Rothstein R, Schned A, et al. The development of dysplasia and adenocarcinoma during endoscopie surveillance of Barrett's esophagus. Am J Gastroenterol 1998;93:536-41.
6. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
7. Reid BJ, Blount PL, Rubin CE, et al. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopie surveillance of a cohort. Gastroenterology 1992:102:1212-9.
8. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's esophagus. Gut 1991; 32:1441-6.
9. Sampliner RE, Garewal HS, Fennerty MB, et al. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
10. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar-lined esophagus: A new endoscopie diagnostic criterion. Gastrointest Endosc 1987;33:413-6.
11. Falk GW, Rice TW, Goldblum JR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's Esophagus with high-grade dysplasia. Gastrointest Endosc 1999;49:170-6.
12. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
13. Robertson CS, Mayberry JF, Nicholson DA, et al. Value of endoscopie surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg 1988;75:760-3.
14. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990:99:918-22.
15. Iftikhar SY, James PD, Steele RJC, et al. Length of Barrett's oesophagus: An important factor in the development of dysplasia and adenocarcinoma. Gut 1992;33:1155-8.
16. Sharma P, Morales TG, Bhattacharyya A, et al. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up. Am J Gastroenterol 1997;92:2012-6.
17. Bonelli L, Gruppo operative per lo studio delle precancerosi esofagee (GOSPE). Barrett's esophagus: Results of a multi. centric survey. Endoscopy 1993;25(suppl):652-4.